<DOC>
	<DOCNO>NCT02171780</DOCNO>
	<brief_summary>To investigate safety , tolerability , pharmacokinetics BI 1744 CL</brief_summary>
	<brief_title>A Study Assess Safety , Tolerability Pharmacokinetics Single Rising Inhaled Doses BI 1744 CL Healthy Male Female Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Olodaterol</mesh_term>
	<criteria>The subject healthy base upon complete medical history , include physical examination , regard vital sign ( BP , PR ) , 12lead ECG measurement , clinical laboratory test . There find deviate normal clinical relevance . There evidence clinically relevant concomitant disease The subject least 21 year old old 50 year The subject 's body mass index ( BMI ) least 18.5 kg/m2 less 30 kg/m2 The subject sign dated write informed consent prior admission study accordance GCP ( Good Clinical Practice ) local legislation The subject find medical examination ( include BP , PR , ECG measurement ) deviate normal clinical relevance The subject surgery gastrointestinal tract ( except appendectomy ) The subject diagnosis gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunological hormonal disorder The subject diagnosis diseases central nervous system ( epilepsy ) psychiatric disorder neurological disorder The subject history relevant orthostatic hypotension , faint spell blackouts The subject diagnosis chronic relevant acute infection The subject history relevant allergy/hypersensitivity ( include allergy drug excipients ) judge clinically relevant investigator The subject take drug long halflife ( &gt; 24 hour ) within least one month le 10 halflives respective drug prior randomisation The subject use drug might reasonably influence result trial base knowledge time protocol preparation within 10 day prior randomisation The subject participate another trial investigational drug within two month prior randomisation The subject heavily smoker ( &gt; 10 cigarette &gt; 3 cigar &gt; 3 pipes/day ) The subject able refrain smoke trial day judge investigator The subject use 60 g alcohol day ) The subject use drug The subject donate 100 mL blood within four week prior randomisation The subject perform excessive physical activity within one week prior randomisation The subject laboratory value outside reference range clinical relevance The subject able comply dietary regimen study centre . The following exclusion criterion specific study due know class side effect profile ÃŸ2mimetics : The subject diagnosis asthma history pulmonary hyperreactivity The subject diagnosis hyperthyrosis The subject diagnosis allergic rhinitis need treatment The subject diagnosis clinically relevant cardiac arrhythmia The subject diagnosis paroxysmal tachycardia ( &gt; 100 beat per minute ) . For female subject : Pregnancy Positive pregnancy test No adequate contraception e.g . oral contraception , sterilisation , IUD ( intrauterine device ) . Females surgically sterile ask additionally use barrier contraception method ( e.g . condom ) prior administration study medication , study least one month release study Inability maintain adequate contraception whole study period Lactation period</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>